On the agenda - NICE rejects liver cancer treatment
In a nutshell The National Institute for Health and Clinical Excellence has come under fire for denying NHS funding for its primary liver cancer treatment. The government drug rationing body rejected the drug on the grounds that it was not a cost-effective use of NHS resources.

Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>